semaglutide vs tirzepatide weight loss efficacy semaglutide: A new battle in obesity treatment Tirzepatide outperformed semaglutide weight-loss drug

We're treating these medications as standalone solutions rather than tools within a comprehensive metabolic health program

We have reviewed the metabolic effects of these drugs in relation to improvement of diabetic hyperglycaemia and fatty liver disease, as well as peripheral metabolism and insulin resistance

Januvia is an approved medicine for type 2 diabetes

Our innovative GLP-1 and Amylin protocols deliver sustainable results

It helps regulate blood sugar and often leads to significant weight loss

Nevertheless, bone consequences of intentional weight loss interventions in PwO are well known: (i) significant weight loss induced by caloric restriction and bariatric surgery results in accelerated bone turnover and bone loss, and (ii) unlike caloric restriction interventions, PwO experience a substantial deterioration in bone microarchitecture and strength associated with an increased risk of fracture after bariatric surgery especially malabsorptive procedures